We have read the case report of Kutlu and Metin with great interest. 1 They have reported a patient with psoriasis and Covid-19 treated with hydroxychloroquine and oseltamivir. The patient developed exacerbation of psoriasis at fourth day of this treatment. They suggested that the exacerbation of psoriasis was due to the use of hydroxychloroquine, while they briefly discussed the possibility that Covid-19 disease might trigger the exacerbation of psoriasis. We have recently seen a patient with psoriasis and Covid-19 who may contribute to psoriasis and Covid-19 interaction. A 48-year-old female was admitted with fever, cough, shortness of breath, and exacerbation of psoriatic lesions. She had a diagnosis of psoriasis for 30 years given several systemic and topical drugs: She used acitretin, 30 mg/day, for 5 weeks 3 years ago, and methotrexate (first oral 15 mg/week, 6 weeks, then subcutaneous 25 mg/week, 8 weeks) with folic acid, 1.5 years ago. Her last treatment was topical: